Pfizer

AstraZeneca Leaves Door Ajar to Pfizer, Despite Hurdles

AstraZeneca's boss said on Wednesday he would engage with Pfizer if the price was right and the risks posed from forcing the British drugmaker's operations into the U.S. company's new three-unit model were addressed. May 15, 2014
file-photo-people-riding-a-motorcycle-in-front-of-the-office-of-ranbaxy-laboratories-at-gurgaon

Ranbaxy Posts Loss after Write-offs on U.S. Import Bans

Drugmaker Ranbaxy Laboratories Ltd (RANB.NS), which has agreed to be acquired by Sun Pharmaceutical Industries Ltd (SUN.NS) for $3.2 billion, posted a loss in the March quarter, hit by write-offs related to regulatory sanctions. May 10, 2014